Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000932934 | SCV001078626 | likely benign | Epidermodysplasia verruciformis | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002544464 | SCV003680426 | uncertain significance | Inborn genetic diseases | 2022-09-22 | criteria provided, single submitter | clinical testing | The c.118C>G (p.P40A) alteration is located in exon 2 (coding exon 1) of the TMC8 gene. This alteration results from a C to G substitution at nucleotide position 118, causing the proline (P) at amino acid position 40 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |